51
|
Rush H, Roca J, Dalby M, Smith D, Lal R, Spicer J, Montes A, Karapanagiotou E. 77 Systemic therapy is safe and effective in octogenarians with advanced lung cancer. Lung Cancer 2016. [DOI: 10.1016/s0169-5002(16)30094-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
52
|
Garcia-Orellana M, Ariño P, Montes A, Arbones E. [Assessment of patient-education on obstetric epidural analgesia received in the third quarter of pregnancy]. Rev Esp Anestesiol Reanim 2015; 62:542. [PMID: 25799288 DOI: 10.1016/j.redar.2015.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2014] [Revised: 02/02/2015] [Accepted: 02/03/2015] [Indexed: 06/04/2023]
Affiliation(s)
- M Garcia-Orellana
- Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Parc de Salut Mar, Hospital del Mar, Barcelona, España.
| | - P Ariño
- Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Parc de Salut Mar, Hospital del Mar, Barcelona, España
| | - A Montes
- Unidad de Tratamiento de Dolor, Parc de Salut Mar, Hospital del Mar, Barcelona, España
| | - E Arbones
- Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Parc de Salut Mar, Hospital del Mar, Barcelona, España; Unidad de Tratamiento de Dolor, Parc de Salut Mar, Hospital del Mar, Barcelona, España
| |
Collapse
|
53
|
Ferreiro-Iglesias A, Montes A, Pérez-Pampín E, Carreira P, Joven B, Caliz R, Ferrer M, Moreno-Ramos M, Raya E, Magro C, Vasilopoulos Y, Sarafidou T, Balsa A, Pascual-Salcedo D, Fernández-Nebro A, Ordόñez M, Alegre-Sancho J, Márquez A, Navarro F, Moreira V, Blanco F, Narvaez J, Cañete J, Martin J, Gόmez-Reino J, Gonzalez A. OP0125 Replication of GWAS of Response to TNF Inhibitors in Patients with Rheumatoid Arthritis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
54
|
Chinnarasu C, Montes A, Fernandez-Ponce M, Casas L, Mantell C, Pereyra C, de la Ossa EM, Pattabhi S. Natural antioxidant fine particles recovery from Eucalyptus globulus leaves using supercritical carbon dioxide assisted processes. J Supercrit Fluids 2015. [DOI: 10.1016/j.supflu.2015.03.013] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
55
|
Ferreiro-Iglesias A, Montes A, Perez-Pampin E, Cañete JD, Raya E, Magro-Checa C, Vasilopoulos Y, Sarafidou T, Caliz R, Ferrer MA, Joven B, Carreira P, Balsa A, Pascual-Salcedo D, Blanco FJ, Moreno-Ramos MJ, Fernández-Nebro A, Ordóñez MC, Alegre-Sancho JJ, Narváez J, Navarro-Sarabia F, Moreira V, Valor L, García-Portales R, Marquez A, Martin J, Gómez-Reino JJ, Gonzalez A. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis. Pharmacogenomics J 2015; 16:137-40. [PMID: 25896535 DOI: 10.1038/tpj.2015.29] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/09/2014] [Revised: 02/16/2015] [Accepted: 03/02/2015] [Indexed: 01/21/2023]
Abstract
Genetic biomarkers could be useful for orienting treatment of patients with rheumatoid arthritis (RA), but none has been convincingly validated yet. Putative biomarkers include 14 single nucleotide polymorphisms that have shown association with response to TNF inhibitors (TNFi) in candidate gene studies and that we assayed here in 755 RA patients. Three of them, in the PTPRC, IL10 and CHUK genes, were significantly associated with response to TNFi. The most significant result was obtained with rs10919563 in PTPRC, which is a confirmed RA susceptibility locus. Its RA risk allele was associated with improved response (B=0.33, P=0.006). This is the second independent replication of this biomarker (P=9.08 × 10(-8) in the combined 3003 RA patients). In this way, PTPRC has become the most replicated genetic biomarker of response to TNFi. In addition, the positive but weaker replication of IL10 and CHUK should stimulate further validation studies.
Collapse
Affiliation(s)
- A Ferreiro-Iglesias
- Laboratorio de Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain
| | - A Montes
- Laboratorio de Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain
| | - E Perez-Pampin
- Laboratorio de Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain
| | - J D Cañete
- Rheumatology Unit, Hospital Clinic, IDIBAPS, Barcelona, Spain
| | - E Raya
- Department of Rheumatology, Hospital Clínico San Cecilio, Granada, Spain
| | - C Magro-Checa
- Department of Rheumatology, Hospital Clínico San Cecilio, Granada, Spain
| | - Y Vasilopoulos
- Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece
| | - T Sarafidou
- Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece
| | - R Caliz
- Rheumatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain
| | - M A Ferrer
- Rheumatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain
| | - B Joven
- Reumatology Department, Hospital 12 de Octubre, Madrid, Spain
| | - P Carreira
- Reumatology Department, Hospital 12 de Octubre, Madrid, Spain
| | - A Balsa
- Department of Rheumatology and Institute for Health Research (IdiPAZ), University Hospital La Paz. Madrid, Spain
| | - D Pascual-Salcedo
- Immunology Unit, Instituto de Investigación Hospital Universitario La Paz, Hospital Universitario La Paz, Madrid, Spain
| | - F J Blanco
- Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), A Coruña, Spain.,Department of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
| | - M J Moreno-Ramos
- Department of Rheumatology, Hospital Virgen de la Arrixaca, Murcia, Spain
| | - A Fernández-Nebro
- UGC de Reumatología, Instituto deInvestigación Biomédica de Málaga (IBIMA), HRU de Málaga, Universidad de Málaga, Málaga, Spain
| | - M C Ordóñez
- UGC de Reumatología, Instituto deInvestigación Biomédica de Málaga (IBIMA), HRU de Málaga, Universidad de Málaga, Málaga, Spain
| | | | - J Narváez
- Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain
| | - F Navarro-Sarabia
- Rheumatology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - V Moreira
- Rheumatology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - L Valor
- Rheumatology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - R García-Portales
- Department of Rheumatology, Hospital Virgen de la Victoria, Málaga, Spain
| | - A Marquez
- Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain
| | - J Martin
- Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain
| | - J J Gómez-Reino
- Laboratorio de Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.,Department of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
| | - A Gonzalez
- Laboratorio de Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain
| |
Collapse
|
56
|
Charlton P, Josephides E, Karapanagiotou E, Montes A, Spicer J, Lal R. Duration and Tolerance of Maintenance Pemetrexed (MPEM) Treatment for Advanced Non-Small Cell Lung Cancer. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv050.35] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
57
|
Concha-Garzón MJ, Solano-López G, Montes A, Fraga J, Sánchez J. Follicular allergic contact dermatitis due to methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) in a rinse-off soap product. Clin Exp Dermatol 2015; 40:690-1. [DOI: 10.1111/ced.12583] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/10/2014] [Indexed: 11/29/2022]
Affiliation(s)
| | - G. Solano-López
- Department of Dermatology; Hospital de La Princesa; Madrid Spain
| | - A. Montes
- Department of Dermatology; Hospital de La Princesa; Madrid Spain
| | - J. Fraga
- Department of Dermatopathology; Hospital de La Princesa; Madrid Spain
| | - J. Sánchez
- Department of Dermatology; Hospital de La Princesa; Madrid Spain
| |
Collapse
|
58
|
Charlton P, Karapanagiotou E, Montes A, Spicer J, Lal R. 60: Discontinuation of maintenance pemetrexed (mPEM) in non-small cell lung cancer (NSCLC) due to renal failure. Lung Cancer 2015. [DOI: 10.1016/s0169-5002(15)50060-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
59
|
Achury C, Domènech A, Estorch M, Jaller R, Montes A, Carrió. I. Riñón ectópico supernumerario. Un hallazgo incidental. Rev Esp Med Nucl Imagen Mol 2014; 33:384-5. [DOI: 10.1016/j.remn.2013.10.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2013] [Revised: 10/29/2013] [Accepted: 10/30/2013] [Indexed: 11/30/2022]
|
60
|
Achury C, Domènech A, Estorch M, Jaller R, Montes A, Carrió I. Ectopic supernumerary kidney. A casual finding. Rev Esp Med Nucl Imagen Mol 2014. [DOI: 10.1016/j.remnie.2014.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
61
|
O'Brien M, Gaafar R, Hasan B, Menis J, Cufer T, Popat S, Woll P, Surmont V, Georgoulias V, Montes A, Blackhall F, Hennig I, Schmid-Bindert G, Baas P. Double Blind Randomized Phase III Study of Maintenance Pazopanib® (Pz) Versus Placebo (P) in Non Small Cell Lung Cancer (Nsclc) Patients (Pts) Non Progressive After First Line Chemotherapy [Ct] (Eortc Lung Cancer Group, 08092): Mapping. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu349.23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
62
|
Kristeleit R, Shapira-Frommer R, Burris H, Patel M, Lorusso P, Oza A, Balmaña J, Domchek S, Chen L, Montes A, Plummer R, Arkenau H, Maloney L, Dominy E, Shapiro G. Phase 1/2 Study of Oral Rucaparib: Updated Phase 1 and Preliminary Phase 2 Results. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu338.8] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
63
|
Galán I, Mayo E, López MJ, Pérez-Ríos M, Fu M, Martínez-Sánchez JM, Schiaffino A, Moncada A, Montes A, Nebot M, Fernández E. Validity of self-reported exposure to second-hand smoke in hospitality venues. Environ Res 2014; 133:1-3. [PMID: 24906061 DOI: 10.1016/j.envres.2014.04.029] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/03/2014] [Revised: 04/14/2014] [Accepted: 04/23/2014] [Indexed: 06/03/2023]
Abstract
The aim was to assess the validity of self-reported exposure to second-hand smoke (SHS) in 50 hospitality venues of Madrid (Spain) in 2010, taking as a reference vapour-phase nicotine measured by active sampling. The questions posed in the questionnaire permitted distinguishing between the different levels of SHS. However, the moderate relationship found (Spearman׳s correlation=0.387, p<0.001) suggests that intensity of exposure to SHS in hospitality venues, based solely on self-reported information, should be used with caution.
Collapse
Affiliation(s)
- Iñaki Galán
- National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid/IdiPAZ, Madrid, Spain.
| | - Elga Mayo
- National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain
| | - María J López
- Public Health Agency of Barcelona, Barcelona, Spain; Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Spain; Institute of Biomedical Research (IIB Sant Pau), Barcelona, Spain
| | - Mónica Pérez-Ríos
- Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Spain; Epidemiology Unit, Galician Directorate for Public Health, Galician Health Authority, Santiago de Compostela, Spain; Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain
| | - Marcela Fu
- Tobacco Control Unit, Cancer Control and Prevention Programme, Institut Català d׳ Oncologia - ICO, L׳Hospitalet de Llobregat, Barcelona, Spain; Cancer Control and Prevention Group, Institut d׳Investigació Biomèdica de Bellvitge - IDIBELL, L׳Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, School of Medicine-Campus de Bellvitge, Universitat de Barcelona, L׳Hospitalet de Llobregat, Barcelona, Spain
| | - Jose M Martínez-Sánchez
- Tobacco Control Unit, Cancer Control and Prevention Programme, Institut Català d׳ Oncologia - ICO, L׳Hospitalet de Llobregat, Barcelona, Spain; Cancer Control and Prevention Group, Institut d׳Investigació Biomèdica de Bellvitge - IDIBELL, L׳Hospitalet de Llobregat, Barcelona, Spain; Biostatistics Unit, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain
| | - Anna Schiaffino
- Tobacco Control Unit, Cancer Control and Prevention Programme, Institut Català d׳ Oncologia - ICO, L׳Hospitalet de Llobregat, Barcelona, Spain
| | - Albert Moncada
- Community Health Unit, Terrassa City Council, Terrassa, Spain
| | - Agustín Montes
- Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Spain; Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain
| | - Manel Nebot
- Public Health Agency of Barcelona, Barcelona, Spain; Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Spain; Institute of Biomedical Research (IIB Sant Pau), Barcelona, Spain; Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain
| | - Esteve Fernández
- Tobacco Control Unit, Cancer Control and Prevention Programme, Institut Català d׳ Oncologia - ICO, L׳Hospitalet de Llobregat, Barcelona, Spain; Cancer Control and Prevention Group, Institut d׳Investigació Biomèdica de Bellvitge - IDIBELL, L׳Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, School of Medicine-Campus de Bellvitge, Universitat de Barcelona, L׳Hospitalet de Llobregat, Barcelona, Spain
| |
Collapse
|
64
|
Montes A, Perez-Pampín E, Bόveda M, Gόmez-Reino J, González A. OP0178 Antibodies against Carbamylated Proteins (ANTI-CARP), A New Type of Autoantibody, in Spanish Patients with Rheumatoid Arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.5427] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
65
|
Otero R, Arellano E, Font C, Montes A, Elias T, Jara L, Carmona-Bayonas A. C0396: Thrombophilia in Thrombosis and Cancer. Thromb Res 2014. [DOI: 10.1016/s0049-3848(14)50333-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
66
|
Montes A, Kin N, Gordillo M, Pereyra C, de la Ossa EM. Polymer–naproxen precipitation by supercritical antisolvent (SAS) process. J Supercrit Fluids 2014. [DOI: 10.1016/j.supflu.2014.02.004] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
67
|
Achury C, Estorch M, Domènech A, Camacho V, Flotats A, Jaller R, Geraldo L, Deportós J, Montes A, Carrió I. [Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies]. Rev Esp Med Nucl Imagen Mol 2014; 33:205-9. [PMID: 24560597 DOI: 10.1016/j.remn.2013.12.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2013] [Revised: 11/23/2013] [Accepted: 12/05/2013] [Indexed: 01/31/2023]
Abstract
OBJECTIVE Thyroid findings or incidentalomas in (18)F-FDG PET/CT studies are relatively frequent, being its clinical significance subject of controversy. The aim of this study was to show our experience in the detection of thyroid incidentalomas by PET/CT studies as well as its follow up. MATERIAL AND METHODS A retrospective and descriptive review was conducted on patients who had thyroid incidentalomas detected in (18)F-FDG PET/CT studies between June 2010 and March 2013. Patient's medical records were reviewed for age, genre, maximum standardized uptake value (SUVmax), thyroid diseases, TSH and antithyroid antibodies levels, ultrasound, fine-needle aspiration (FNA) and cytology. RESULTS 4085 PET/CT studies for several purposes were performed. Eighty-three of these studies (2.03%) showed thyroid incidentalomas. Thirty-seven patients showed a diffuse increase of glucose metabolism in the thyroid gland and 46 showed a focal increase of glucose metabolism. Five out of 46 patients with focal uptake were diagnosed of a neoplastic disease by cytology (11%). The SUVmax of malignant pathology did not differ from that of benign thyroid diseases (Mean: 10,26 and 5,92 respectively). CONCLUSION In our experience, focal thyroid incidentalomas detected in (18)F-FDG PET/CT studies are related to a significant risk of malignancy (11%). Therefore, in these situations, an ultrasound study with fine needle biopsy should be recommended. Moreover, a diffuse increase of glucose metabolism in the thyroid gland is often associated with benign thyroid pathology.
Collapse
Affiliation(s)
- C Achury
- Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
| | - M Estorch
- Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - A Domènech
- Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - V Camacho
- Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - A Flotats
- Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - R Jaller
- Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - L Geraldo
- Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - J Deportós
- Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - A Montes
- Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - I Carrió
- Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| |
Collapse
|
68
|
Thillai K, Donovan V, Soultati A, Kandasamy R, Van Schalkwyk M, Mather R, Najaryan N, Spicer J, Montes A, Lal R, Benepal T. 68 The prevalence of hyponatraemia amongst patients with newly diagnosed thoracic malignancies. Lung Cancer 2014. [DOI: 10.1016/s0169-5002(14)70068-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
69
|
Thillai K, Soultati A, Lawrence H, Spicer J, Lal R, Montes A. 55 Lung cancer presenting with symptomatic bone metastases: Are we doing enough? Lung Cancer 2014. [DOI: 10.1016/s0169-5002(14)70055-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
70
|
Beddowes E, Hatipoglu E, Montes A, Spicer J, Moller H, Lal R. 16 Characterising the use and impact of bisphosphonates in patients with bone metastases from non-small cell lung cancer; a single centre experience. Lung Cancer 2014. [DOI: 10.1016/s0169-5002(14)70017-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
71
|
Montes A, Litwinowicz AA, Gradl U, Gordillo MD, Pereyra C, Martínez de la Ossa EJ. Exploring High Operating Conditions in the Ibuprofen Precipitation by Rapid Expansion of Supercritical Solutions Process. Ind Eng Chem Res 2013. [DOI: 10.1021/ie402408j] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- A. Montes
- Department of Chemical Engineering
and Food Technology, Faculty of Sciences, University of Cádiz, International
Excellence Agrifood Campus (CeiA3), 11510 Puerto Real, Cádiz, Spain
| | - A. A. Litwinowicz
- Department of Chemical Engineering
and Food Technology, Faculty of Sciences, University of Cádiz, International
Excellence Agrifood Campus (CeiA3), 11510 Puerto Real, Cádiz, Spain
| | - U. Gradl
- Department of Chemical Engineering
and Food Technology, Faculty of Sciences, University of Cádiz, International
Excellence Agrifood Campus (CeiA3), 11510 Puerto Real, Cádiz, Spain
| | - M. D. Gordillo
- Department of Chemical Engineering
and Food Technology, Faculty of Sciences, University of Cádiz, International
Excellence Agrifood Campus (CeiA3), 11510 Puerto Real, Cádiz, Spain
| | - C. Pereyra
- Department of Chemical Engineering
and Food Technology, Faculty of Sciences, University of Cádiz, International
Excellence Agrifood Campus (CeiA3), 11510 Puerto Real, Cádiz, Spain
| | - E. J. Martínez de la Ossa
- Department of Chemical Engineering
and Food Technology, Faculty of Sciences, University of Cádiz, International
Excellence Agrifood Campus (CeiA3), 11510 Puerto Real, Cádiz, Spain
| |
Collapse
|
72
|
Fu M, Martínez-Sánchez JM, Galán I, Pérez-Ríos M, Sureda X, López MJ, Schiaffino A, Moncada A, Montes A, Nebot M, Fernández E. Variability in the correlation between nicotine and PM2.5 as airborne markers of second-hand smoke exposure. Environ Res 2013; 127:49-55. [PMID: 24176412 DOI: 10.1016/j.envres.2013.09.003] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/12/2013] [Revised: 09/20/2013] [Accepted: 09/26/2013] [Indexed: 06/02/2023]
Abstract
The aim of this study was to assess the relationship between particulate matter of diameter≤2.5 µm (PM2.5) and airborne nicotine concentration as markers of second-hand smoke exposure with respect to the setting studied, the intensity of exposure, and the type of environment studied (indoors or outdoors). Data are derived from two independent studies that simultaneously measured PM2.5 and nicotine concentrations in the air as airborne markers of second-hand smoke exposure in public places and workplaces, including health care centres, bars, public administration offices, educational centres, and transportation. We obtained 213 simultaneous measures of airborne nicotine and PM2.5. Nicotine in the air was measured with active samplers containing a sodium bisulphate-treated filter that was analysed by gas chromatography/mass spectrometry. PM2.5 was measured with a SidePak AM510 Personal Aerosol Monitor. We calculated Spearman's rank correlation coefficient and its 95% confidence intervals (95% CI) between both measures for overall data and stratified by setting, type of environment (indoors/outdoors), and intensity of second-hand smoke exposure (low/high, according to the global median nicotine concentration). We also fitted generalized regression models to further explore these relationships. The median airborne nicotine concentration was 1.36 µg/m3, and the median PM2.5 concentration was 32.13 µg/m3. The overall correlation between both markers was high (Spearman's rank correlation coefficient=0.709; 95% CI: 0.635-0.770). Correlations were higher indoors (Spearman's rank correlation coefficient=0.739; 95% CI: 0.666-0.798) and in environments with high second-hand smoke exposure (Spearman's rank correlation coefficient=0.733; 95% CI: 0.631-0.810). The multivariate analysis adjusted for type of environment and intensity of second-hand smoke exposure confirmed a strong relationship (7.1% increase in geometric mean PM2.5 concentration per µg/m3 nicotine concentration), but only in indoor environments in a stratified analysis (6.7% increase; 95% CI: 4.3-9.1%). Although the overall correlation between airborne nicotine and PM2.5 is high, there is some variability regarding the type of environment and the intensity of second-hand smoke exposure. In the absence of other sources of combustion, air nicotine and PM2.5 measures can be used indoors, while PM2.5 should be used outdoors with caution.
Collapse
Affiliation(s)
- Marcela Fu
- Tobacco Control Unit, Cancer Control and Prevention Programme, Institut Català d'Oncologia-ICO, Av. Granvia de L'Hospitalet 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain; Cancer Control and Prevention Group, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, Av. Granvia de L'Hospitalet 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, School of Medicine, Universitat de Barcelona-Pavelló de Govern, c/Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
73
|
Garcia-Orellana M, Herms R, Rodríguez Cosmen C, Montes A. [Analysis of post-cesarean analgesia protocols in a University Hospital]. ACTA ACUST UNITED AC 2013; 61:228-9. [PMID: 23890875 DOI: 10.1016/j.redar.2013.05.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2013] [Revised: 05/12/2013] [Accepted: 05/16/2013] [Indexed: 11/28/2022]
Affiliation(s)
- M Garcia-Orellana
- Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Parc de Salut Mar, Hospital del Mar, Barcelona, España.
| | - R Herms
- Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Parc de Salut Mar, Hospital del Mar, Barcelona, España
| | - C Rodríguez Cosmen
- Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Parc de Salut Mar, Hospital del Mar, Barcelona, España
| | - A Montes
- Servicio de Anestesiología, Reanimación y Terapéutica del Dolor, Parc de Salut Mar, Hospital del Mar, Barcelona, España
| |
Collapse
|
74
|
Montes A, Perez-Pampin E, Navarro-Sarabia F, Moreira V, Rodríguez de la Serna A, Magallanes B, Vasilopoulos Y, Sarafidou T, Fernández-Nebro A, Ordóñez MDC, Narváez J, Cañete JD, Isaacs J, Morgan A, Barton A, Wilson AG, Gomez-Reino JJ, González A. THU0009 Reduced Clinical Improvement in Rheumatoid Arthritis Patients Showing IgG1 Allotype -Infliximab Incompatibility. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.537] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
75
|
Montes A, Baldauf E, Gordillo MD, Pereyra CM, Martínez de la Ossa EJ. Polymer encapsulation of amoxicillin microparticles by SAS process. J Microencapsul 2013; 31:16-22. [DOI: 10.3109/02652048.2013.799242] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
76
|
Engay BM, Irún M, Sarría L, Andrade M, Murillo I, Montes A, Pocoví M, Giraldo P. P-182 Analysis of efficacy and safety of two iron chelators in patients with iron overload (QueLaFer study). Leuk Res 2013. [DOI: 10.1016/s0145-2126(13)70230-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
77
|
Montes A, Nunes A, Gordillo MD, Pereyra C, Duarte CMM, Martínez de la Ossa EJ. Amoxicillin and Ethyl Cellulose Precipitation by Two Supercritical Antisolvent Processes. Chem Eng Technol 2013. [DOI: 10.1002/ceat.201200429] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
78
|
Compton S, Michalarea V, Pintus E, Thomas R, Colvin M, Tindale-Paul P, Eestila S, Montes A, Spicer J, Lal R. 129 Treating non small cell lung cancer with erlotinib: the Nurse Led clinic experience. Lung Cancer 2013. [DOI: 10.1016/s0169-5002(13)70129-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
79
|
Lopez MJ, Fernandez E, Perez-Rios M, Martinez-Sanchez JM, Schiaffino A, Galan I, Moncada A, Fu M, Montes A, Salto E, Nebot M. Impact of the 2011 Spanish Smoking Ban in Hospitality Venues: Indoor Secondhand Smoke Exposure and Influence of Outdoor Smoking. Nicotine Tob Res 2012; 15:992-6. [DOI: 10.1093/ntr/nts218] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
80
|
Ahilathirunayagam⁎ S, Kalsi T, Husain Y, Wittenbecher F, Zohree MA, Babic-illman A, Moss C, Spicer J, Montes A, Harari D, Lal R. Chemotherapy dose density in elderly lung cancer patients requires frequent modifications: A retrospective case series from January 2011 to July 2012. J Geriatr Oncol 2012. [DOI: 10.1016/j.jgo.2012.10.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
81
|
Montes A, Gordillo MD, Schindhelm S, Pereyra C, Martinez De La Ossa EJ. Supercritical Antisolvent Precipitation of Ethyl Cellulose. Particulate Science and Technology 2012. [DOI: 10.1080/02726351.2011.594867] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
82
|
Cuevas E, Canesin G, Santos V, Montes A, Moreno-Bueno G, Portillo F, Cano A. 313 Role of Intracellular LOXL2 in the Regulation of Epithelial Plasticity. Eur J Cancer 2012. [DOI: 10.1016/s0959-8049(12)71005-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
83
|
Pérez-Ríos M, Schiaffino A, López MJ, Nebot M, Galán I, Fu M, Martínez-Sánchez JM, Moncada A, Montes A, Ariza C, Fernández E. Questionnaire-based second-hand smoke assessment in adults. Eur J Public Health 2012; 23:763-7. [DOI: 10.1093/eurpub/cks069] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
84
|
Montes A, Gordillo M, Pereyra C, Martínez de la Ossa E. Co-precipitation of amoxicillin and ethyl cellulose microparticles by supercritical antisolvent process. J Supercrit Fluids 2011. [DOI: 10.1016/j.supflu.2011.05.002] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
85
|
Jayaro C, De La Vega I, Bayon-Palomino C, Díaz-Marsá M, Montes A, Tajima K, López-Ibor JJ, Carrasco JL. Depressive-type emotional response pattern in impulsive-aggressive patients with borderline personality disorder. J Affect Disord 2011; 135:37-42. [PMID: 21807413 DOI: 10.1016/j.jad.2011.06.040] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/31/2011] [Accepted: 06/28/2011] [Indexed: 11/18/2022]
Abstract
INTRODUCTION Borderline personality disorder (BPD) is typically characterized by severe affective dysregulation leading to impulsive behaviors. Accordingly, preliminary data suggest the hypothesis that BPD patients could have a specific and altered pattern of subjective emotional response to stimuli. The nature of the emotional response in BPD can be compared with other affective disorders and provide further insight on the nosological proximity with other psychiatric disorders. METHODS Subjective emotional response was investigated in 19 patients with DSM-IV BPD with no current depressive episode and in 19 healthy control subjects by using the International Affective Picture System (IAPS). The intensity of arousal, valence and dominance was rated in response to 60 images categorized as pleasant, unpleasant and neutral by using a self-assessment instrument. ANOVA of multiple factors was used for between-groups comparisons. RESULTS The obtained pattern showed that BPD patients considered the unpleasant and neutral images as less aversive than controls, but the activation that these images induced was higher. Patients showed significantly greater arousal than controls for unpleasant and neutral images (p<0.05) but presented greater valence (more positive emotion) for these images (p<0.05). In addition, BPD patients showed lower dominance (greater insecurity and dyscomfort) for positive images (p<0.05). CONCLUSIONS The subjective emotional response pattern of BPD patients suggests a trait of vulnerability to pleasant stimuli and is similar to the pattern found in depressive patients in previous studies. This supports the evidence that BPD could in part be related with the spectrum of the affective temperament and affective disorders.
Collapse
Affiliation(s)
- C Jayaro
- Departamento de Psicología, Universidad Metropolitana, Hospital Neuropsiquiátrico Jesús Mata de Gregorio, Caracas, Venezuela
| | | | | | | | | | | | | | | |
Collapse
|
86
|
Díaz-Marsá M, Carrasco JL, López-Ibor M, Moratti S, Montes A, Ortiz T, López-Ibor JJ. Orbitofrontal dysfunction related to depressive symptomatology in subjects with borderline personality disorder. J Affect Disord 2011; 134:410-5. [PMID: 21641654 DOI: 10.1016/j.jad.2011.04.034] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/12/2011] [Accepted: 04/27/2011] [Indexed: 10/18/2022]
Abstract
OBJECTIVE In order to explore the relationships of fronto-limbic dysfunction with the clinical features of borderline personality disorder (BPD), the authors investigated brain electrophysiological activity in BPD patients following stimulation with emotionally arousing images. METHODS Seventeen non-medicated patients with borderline personality disorder were studied with magneto-encephalography. Regional cortical activities were obtained by minimum norm estimate (MNE) of steady-state visual evoked fields (ssVEFs). Linear regression models were conducted to explore clinical correlates of brain activity. RESULTS Although no interaction group × picture category × brain region was found, a significant interaction group × brain region appeared for orbito-frontal cortex (OFC). BPD patients showed significantly reduced magnetocortical activity in left OFC across all picture categories (F = 26.4; p<.05; F = 31.4). Left OFC activity was inversely correlated with depression score in the BDI (r: -0.48, p < 0.05), with score in the Cornell Dysthymia rating scale (r: -0.52, p < 0.05) and with the number of criteria met for depressive personality disorder (r: -0.44, p < 0.05). Left orbitofrontal activity was also inversely correlated with the global score in the GAF (r-0.63, p < 0.01). No correlations were found between OFC activity and impulsivity or global severity of BPD symptoms. CONCLUSIONS Abnormal functioning at orbitofrontal areas in BPD could be related to the presence of affective symptomatology and is associated with greater functional deterioration of patients.
Collapse
Affiliation(s)
- M Díaz-Marsá
- Institute of Psychiatry and Mental Health, Hospital Clínico San Carlos, Madrid, Spain
| | | | | | | | | | | | | |
Collapse
|
87
|
Rudman SM, Josephs DH, Cambrook H, Karagiannis P, Gilbert AE, Dodev T, Hunt J, Koers A, Montes A, Taams L, Canevari S, Figini M, Blower PJ, Beavil AJ, Nicodemus CF, Corrigan C, Kaye SB, Nestle FO, Gould HJ, Spicer JF, Karagiannis SN. Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity. Clin Exp Allergy 2011; 41:1400-13. [PMID: 21569129 DOI: 10.1111/j.1365-2222.2011.03770.x] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
BACKGROUND IgE antibodies, sequestered into tissues and retained locally by the high-affinity IgE receptor, FcɛRI, on powerful effector cells such as mast cells, macrophages and eosinophils, may offer improvements in the therapy of solid tumours. The chimeric antibody, MOv18 IgE, against the human ovarian carcinoma antigen, folate receptor α (FRα), is more effective than its IgG1 counterpart in xenograft models of ovarian cancer. Although MOv18 IgE binds to a single epitope on FRα and cannot cross-link IgE receptors on basophils, there remains a risk that components in the circulation of ovarian cancer patients might cross-link FRα-MOv18-IgE-receptor-FcɛRI complexes on basophils to cause type I hypersensitivity. OBJECTIVE To assess the propensity for MOv18 used in a therapeutic setting to cause FcɛRI-mediated type I hypersensitivity. METHODS As validated readouts of the potential for MOv18 to cause FcɛRI-mediated type I hypersensitivity we measured release of a granule-stored mediator from a rat basophilic leukaemia cell line RBL SX-38 stably transfected with human tetrameric (αβγ2) FcɛRI, and induction of CD63 on blood basophils from patients with ovarian carcinoma and healthy controls ex vivo. RESULTS Serum FRα levels were increased in ovarian cancer patients compared with healthy controls. MOv18 IgE alone, or in the presence of its antigen recombinant human FRα, or of healthy volunteer (n=14) or ovarian carcinoma patient (n=32) sera, did not induce RBL SX-38 cell degranulation. Exposure to FRα-expressing ovarian tumour cells at target-to-effector ratios expected within tumours induced degranulation. MOv18 IgE did not induce expression of CD63 in blood basophils from either healthy volunteers (n=6), or cancer patients, despite detectable levels of circulating FRα (n=5). CONCLUSION AND CLINICAL RELEVANCE These encouraging data are compatible with the hypothesis that, when ovarian carcinoma patients are treated with MOv18, FcɛRI-mediated activation of effector cells occurs within the tumour mass but not in the circulation mandating, with due caution, further pre-clinical studies.
Collapse
MESH Headings
- Animals
- Antibodies, Monoclonal, Murine-Derived/adverse effects
- Antibodies, Monoclonal, Murine-Derived/genetics
- Antibodies, Monoclonal, Murine-Derived/immunology
- Antibody Specificity
- Antigens, Neoplasm/immunology
- Basophils/immunology
- Carcinoma/immunology
- Carcinoma/therapy
- Cell Degranulation
- Cell Line, Tumor
- Female
- Folate Receptor 1/blood
- Folate Receptor 1/immunology
- Folate Receptor 1/metabolism
- Humans
- Hypersensitivity, Immediate/etiology
- Hypersensitivity, Immediate/immunology
- Immunoglobulin E/genetics
- Immunoglobulin E/immunology
- Ovarian Neoplasms/immunology
- Ovarian Neoplasms/therapy
- Protein Engineering
- Rats
- Receptors, IgE/immunology
- Tetraspanin 30/metabolism
Collapse
Affiliation(s)
- S M Rudman
- NIHR Biomedical Research Centre at Guy's and St Thomas's Hospitals and King's College London, Cutaneous Medicine & Immunotherapy Unit, St John's Institute of Dermatology, Division of Genetics & Molecular Medicine, King's College London School of Medicine, Guy's Hospital, King's College London, London, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
88
|
Garcia J, Montes A, Dürsteler C, Gallart L, Romero A, Puig M. T300 POSTOPERATIVE PAIN OUTCOME AFTER TOTAL KNEE REPLACEMENT (TKR) USING PAIN-OUT SELF-ADMINISTERED QUESTIONNAIRES. ACTA ACUST UNITED AC 2011. [DOI: 10.1016/s1754-3207(11)70218-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
89
|
Nebot M, Manzanares S, López MJ, Ariza C, Galán I, Moncada A, Montes A, Pérez-Ríos M, Schiaffino A, Fernández E. [Estimation of environmental tobacco smoke exposure: review of questionnaires used in Spain]. Gac Sanit 2011; 25:322-8. [PMID: 21680061 DOI: 10.1016/j.gaceta.2011.02.013] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2010] [Revised: 02/08/2011] [Accepted: 02/08/2011] [Indexed: 11/25/2022]
Abstract
INTRODUCTION In the last few years, health surveys and epidemiological studies on smoking have introduced questions on environmental tobacco smoke (ETS) exposure. However, a standardized questionnaire is lacking. METHODS Between January and May 2008, we reviewed surveys containing items on ETS exposure carried out in Spain by public administrations, scientific societies and research institutes. The wording of the questions was reviewed and classified according to the study type, target population, geographical setting and place of exposure. RESULTS We identified 27 surveys that included questions on passive smoking. Most were health surveys (81.5%) and were aimed at the general population (70.4%). The most frequent geographical setting consisted of autonomous regions (48.1%) and the most common place of exposure was the home (88.9%) DISCUSSION The results show wide variability in the questions used. Questionnaire items on ETS exposure should be homogenized to allow comparison of the results of surveys.
Collapse
Affiliation(s)
- Manel Nebot
- Agencia de Salud Pública de Barcelona, España.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
90
|
Okera M, Peacock J, Hobinchetti A, Montes A. The effect of Cockcroft-Gault (CG) measurement of GFR on carboplatin dosage in ovarian cancer patients compared with Cr 51-EDTA. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e15538] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
91
|
Montes A, Okera M, Ayis S, Natas S, Jacques A, Winship A. Predicting response to neoadjuvant chemotherapy (NAC) in epithelial ovarian carcinoma (EOC). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e15555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
92
|
Abstract
ABSTRACTA customary procedure in the protection of monumental buildings is the consolidation of decaying stone by the application of commercial products containing tetraethoxysilane (TEOS). These products polymerize within the porous structure of the decaying stone, significantly increasing the cohesion of the material. However, TEOS-based consolidants suffer practical drawbacks, such as cracking of the network during the drying phase, and significant blocking of the rock pores. These limitations are related to the growth of a dense microporous network of the xerogel inside the stone material, which is typical from TEOS sols. Therefore, the purpose of this work is to increase porosity of the product by including colloidal particles in the starting sol.We prepared a colloid-polymer composite gel using TEOS and a commercial silica colloid. The percentage by weight of silica colloid particles to total silica was 54%. Ethanol and dibutyltindilaurate (DBLT) were chosen as solvent and catalyst, respectively. This catalyst promotes the gelation at a neutral pH, preventing stone decay related to acid or basic catalysis. We characterized the properties playing a key role in consolidation. Data were compared with those obtained using a popular commercial product: Tegovakon V 100 produced by Goldsmith.In spite of the colloidal particle addition, sols exhibited viscosity values close to those of the commercial products, as a consequence of their dispersion in ethanol. A gelation time similar to that of commercial consolidants was maintained, whereas the contained sol was stable over a period of up to six months. Concerning textural parameters, the addition of colloid permitted to obtain a crack-free, mesoporous material structure. This generated a crack-free material whereas the gel from Tegovakon V 100 exhibited cracking.We also evaluated the consolidant efficacy on a biocalcareous stone, one of the most common monumental building stone employed in the southwest of Spain. Three key parameters -penetration depth in the rock, mechanical properties and water vapour diffusivity- were measured. Stone permeation was similar to that from the commercial product. Notably, a significant improvement of compression strength of the stone was observed. Reduction in vapour diffusivity of the treated stone was slightly lower for our gel than for the commercial consolidant.
Collapse
|
93
|
Moreno-Bueno G, Martin A, Moreno R, Montes A, Peinado H, Portillo F, Cano A. 435 LOXL2 as a new marker of basal-like phenotype in breast cancer. EJC Suppl 2010. [DOI: 10.1016/s1359-6349(10)71236-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
94
|
Montes A, Figueras A, Novoa B. Nodavirus encephalopathy in turbot (Scophthalmus maximus): inflammation, nitric oxide production and effect of anti-inflammatory compounds. Fish Shellfish Immunol 2010; 28:281-8. [PMID: 19913100 DOI: 10.1016/j.fsi.2009.11.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/31/2009] [Revised: 10/28/2009] [Accepted: 11/02/2009] [Indexed: 05/04/2023]
Abstract
Nodaviruses are the etiological agents of one of the most serious viral diseases affecting marine fish aquaculture. Nodavirus infection produces an abnormal swimming behaviour and causes encephalopathy and retinopathy associated to important mortalities. The expression of TNF-alpha, IRF-1 and Mx was increased in turbot after nodavirus infection. A significant increase in the production of nitrogen radicals was also observed in experimentally infected turbot. Several anti-inflammatory compounds (the antioxidant N-acetylcysteine, cortisone, dexamethasone, prednisolone and aminoguanidine) were assayed to determine the role of inflammation on nodavirus infection. Cortisone and aminoguanidine were able to accelerate the mortality onset associated to nodavirus infection, modulating the gene expression of TNF-alpha and, in addition, modifying the arrival time of nodavirus to the brain. These results suggest the importance of early inflammatory processes to overcome the infection.
Collapse
Affiliation(s)
- A Montes
- Instituto de Investigaciones Marinas, Consejo Superior de Investigaciones Científicas (CSIC), Eduardo Cabello, 6, 36208 Vigo, Spain
| | | | | |
Collapse
|
95
|
Montes A, de Lobel N, Sawicka L. Surgery for small cell lung cancer (SCLC), where are the patients? Lung Cancer 2010. [DOI: 10.1016/s0169-5002(10)70035-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
96
|
Montes A, Tenorio A, Gordillo M, Pereyra C, Martínez de la Ossa E. Screening design of experiment applied to supercritical antisolvent precipitation of amoxicillin: Exploring new miscible conditions. J Supercrit Fluids 2010. [DOI: 10.1016/j.supflu.2009.10.007] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
97
|
Castaño J, Garnier C, Gonzalez L, Alvaro P, Moreno C, Comps O, Montes A, Martin L, Bulbena A. 601 CHRONIC PAIN AND PSYCHIATRIC DISORDERS. Eur J Pain 2009. [DOI: 10.1016/s1090-3801(09)60604-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- J. Castaño
- Hospital del Mar, Psychiatric and Pain Unit, Barcelona, Spain
| | - C. Garnier
- Hospital del Mar, Psychiatric and Pain Unit, Barcelona, Spain
| | - L. Gonzalez
- Hospital del Mar, Psychiatric and Pain Unit, Barcelona, Spain
| | - P. Alvaro
- Hospital del Mar, Psychiatric and Pain Unit, Barcelona, Spain
| | - C. Moreno
- Hospital del Mar, Psychiatric and Pain Unit, Barcelona, Spain
| | - O. Comps
- Hospital del Mar, Psychiatric and Pain Unit, Barcelona, Spain
| | - A. Montes
- Hospital del Mar, Psychiatric and Pain Unit, Barcelona, Spain
| | - L.M. Martin
- Hospital del Mar, Psychiatric and Pain Unit, Barcelona, Spain
| | - A. Bulbena
- Hospital del Mar, Psychiatric and Pain Unit, Barcelona, Spain
| |
Collapse
|
98
|
Montes A, Sandhu SK, Rothermundt C, Coombes I, A'Hern R, Keyzor C, Thomas A, Kaye S, Gore M. Phase I feasibility study of carboplatin plus capecitabine followed by maintenance capecitabine in patients (pts) with recurrent platinum-sensitive epithelial ovarian cancer (EOC). J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.5564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
5564 Background: In a previous study, we noted a response rate (RR) of 61% for the 3 drug combination of carboplatin, epirubicin and capecitabine in platinum-sensitive recurrent EOC. This combination however resulted in excessive grade (G) 3–4 haematological toxicity (55%) (BJC 2006; 94:74). The current trial therefore assessed the feasibility and efficacy of the 2 drugs, carboplatin and capecitabine as second- or third-line treatment. Methods: Pts were administered carboplatin (AUC5) day 1 and capecitabine at a starting dose of 750 mg/m2 bd, days 1–21, q21 (dose level 1). The capecitabine dose was deescalated to 625 mg/m2 (dose level -1) and 500 mg/m2 (dose level -2) according to toxicity. Pts with an objective response or stable disease received maintenance capecitabine (at the same dose level) for up to 12 months or until progression. Responses were assessed with RECIST criteria and CA-125. Results: 19 of the 20 pts enrolled were evaluable for toxicity and response. Dose-limiting toxicity was observed at dose level 1 (G3 fatigue, G3 diarrhoea, G3 neutropenia of > 14 days; n = 3/5), dose level -1 (G3 angina (n = 2), G3 vomiting, G3 palmar plantar erythema; n = 4/7) and dose level-2 (diarrhoea / fatigue; n = 1/7). One patient had a G3 carboplatin hypersensivity reaction. 8 pts received maintenance capecitabine which was well tolerated. The overall RR was 53% with 10 partial responses and 5 stable diseases. The median progression free survival (PFS) was 6.5 months (m) and the 6mPFS was 63% with 2 pts currently ongoing treatment. The median PFS on maintenance was 3.2 m. Conclusions: The combination was well tolerated at the recommended phase II dose of carboplatin (AUC 5) and capecitabine (500 mg/m2 bd) with partial responses in over half of the cases. [Table: see text]
Collapse
Affiliation(s)
- A. Montes
- Guy's and St Thomas’ Hospital, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - S. K. Sandhu
- Guy's and St Thomas’ Hospital, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - C. Rothermundt
- Guy's and St Thomas’ Hospital, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - I. Coombes
- Guy's and St Thomas’ Hospital, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - R. A'Hern
- Guy's and St Thomas’ Hospital, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - C. Keyzor
- Guy's and St Thomas’ Hospital, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - A. Thomas
- Guy's and St Thomas’ Hospital, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - S. Kaye
- Guy's and St Thomas’ Hospital, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - M. Gore
- Guy's and St Thomas’ Hospital, London, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| |
Collapse
|
99
|
Tajima K, Díaz-Marsá M, Montes A, Fernández García-Andrade R, Casado A, Carrasco JL. [Neuroimaging studies in borderline personality disorder]. Actas Esp Psiquiatr 2009; 37:123-127. [PMID: 19533423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
DSM-IV defines Borderline personality disorder (BPD) as a personality disorder that can be primarily characterized by emotional instability, extremely polarized thought and chaotic interpersonal relations. It is the most common personality disorder. Its prevalence is estimated to be from 0.2% to 1.8% of the general population, and the 76% of them are women. However, despite these data and the different biologic findings, there are few publications on neuroimage about this nosologic entity. Recent studies suggest that a dual cerebral disorder, including frontal and limbic circuits, could be present in characterize BPD. These cerebral areas would also be involved in the serotonergic dysfunction that seems to be related to the impulse dyscontrol and self-aggressive behaviour, characteristic of these patients. Most authors point out the importance of traumatic precedents in the BPD genesis, with a direct relation between stress and the neurobiological findings observed, including the neuroimage changes. The aim of this article is to make a revision of the main neuroimage data found in BPD, including the new techniques such as functional MRI, diffusion tensor MRI and spectroscopy.
Collapse
Affiliation(s)
- K Tajima
- Servicio de Psiquatría, Hospital Clinico San Carlos, Madrid
| | | | | | | | | | | |
Collapse
|
100
|
Adánez G, Castells MT, García Pérez B, Sánchez-Polo MT, Martín Castillo A, Montes A, Ayala I. Effects of atorvastatin on progression-regression of renal injury in hyperlipidemic chickens. Histol Histopathol 2008; 23:1131-42. [PMID: 18581284 DOI: 10.14670/hh-23.1131] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Complex interrelationships exist between hyperlipidemia and the progression of renal injury. The aim of this study was to evaluate the impact of high plasma cholesterol and triglyceride levels on renal structure and the effects of atorvastatin on progression-regression of renal injury. One-hundred chickens were divided into five groups: Group A: Standard diet (SD) for 6 months; Group B: Hyperlipidemic diet (HD) for 6 months; Group C: HD for three months and SD during the next 3 months; Group D: HD for 3 months and SD during the next 3 months, when they received oral atorvastatin (3 mg/kg/d); Group E: HD for the whole 6 months, and atorvastatin (3 mg/kg/d) during the last 3 months. Increased alpha-actine immunostaining was found in glomeruli of groups B and C. An important decrease of immunostaining was observed in glomeruli of atorvastatin treated groups. Group D showed the lowest value for presence of lipids, and significant differences were found with respect to the rest of the groups. The glomeruli of group B presented the highest damage grades and those of group D showed the lowest grades and presented significant differences from the rest of the groups. The combination of atorvastatin therapy and proper diet proved to be effective in promoting renal disease regression. However, the study of several parameters indicates that neither only diet nor atorvastatin in the progression group resulted completely effective in decreasing the progression of the disease.
Collapse
Affiliation(s)
- G Adánez
- Universitary Clinical Hospital, Virgen de la Arrixaca, Murcia, Spain
| | | | | | | | | | | | | |
Collapse
|